NSECertificate under SEBI (Depositories and Participants) Regulations, 20187 Jul 2026 · 7 Jul 2026, 04:57 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Senores Pharmaceuticals Limited · SENORES
✦ AI Summary
Senores Pharmaceuticals Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026, confirming the acceptance or rejection of dematerialized securities and listing of securities on stock exchanges.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Senores Pharmaceuticals Limited has informed the Exchange regarding Certificate pursuant to Regulation 74(5) of SEBI (DP)Regulations,2018 for quarter ended June 30, 2026
Attachments (1)
📄pdf
Download →
SENORES_07072026165746_Intimationunderregulation74signed.pdf
View document text
Date: July 07, 2026
To, To,
Sr. General Manager Sr. General Manager
Listing Department Listing Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street Bandra Kurla Complex
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
BSE Scrip Code: 544319 NSE Symbol: SENORES
Dear Sir/Madam,
Sub: Certificate pursuant to Regulation 74(5) of Securities and Exchange Board of India
(Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026
Please find enclosed herewith a certificate, pursuant to Regulation 74(5) of the Securities and Exchange
Board of India (Depositories and Participants) Regulations, 2018, received from MUFG Intime India
Private Limited, Registrar and Share Transfer Agent of the Company, for the quarter ended June 30, 2026.
Kindly take the same on your records.
Thanking you.
For Senores Pharmaceuticals Limited
Deval Rajnikant Shah
Whole Time Director & CFO
DIN: 00332722
Encl.: As mentioned above
Senores Pharmaceuticals Limited
1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park,
Ambali Bopal Road, Ahmedabad-380054, Gujarat, India
P: +91 79 2999 9857 | E: info@senorespharma.com
W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400083.
Tel: +91 22 4918 6000
www.in.mpms.mufg.com
Date : 01-07-2026
The Compliance Officer/ Company Secretary
SENORES PHARMACEUTICALS LIMITED
1101 TO 1103 11TH FLOOR SOUTH TOWER
ONE 42 OPPOSITE JAYANTILAL PARK
AMBALI BOPAL ROAD
AHMEDABAD
AHMEDABAD
PINCODE : 380054
Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for
dematerialisation during the quarter ended 30th June 2026, were confirmed (accepted/rejected) to the depositories by us and that
securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed.
We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security
certificates received were mutilated and cancelled after due verification by the depository participant and the name of the
depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request
you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry
MUFG Intime India Private Limited
A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services